Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
6.30
-0.06 (-0.94%)
At close: Apr 2, 2025, 4:00 PM
6.40
+0.10 (1.58%)
After-hours: Apr 2, 2025, 7:23 PM EDT

Tenax Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-17.6-7.71-11.05-32.47-9.85
Upgrade
Depreciation & Amortization
-0.010.110.110.11
Upgrade
Loss (Gain) From Sale of Assets
-0-0--
Upgrade
Loss (Gain) From Sale of Investments
---0.010.01
Upgrade
Stock-Based Compensation
1.130.190.370.770.35
Upgrade
Other Operating Activities
0.020.02021.340
Upgrade
Change in Accounts Receivable
0.06-0.31-0.36-0.020.7
Upgrade
Change in Accounts Payable
1.061.65-0.34-0.54-0.54
Upgrade
Change in Other Net Operating Assets
0.520.24-0.12-0.04-0.06
Upgrade
Operating Cash Flow
-14.81-5.9-11.39-10.86-9.27
Upgrade
Capital Expenditures
---0-0.01-0
Upgrade
Sale of Property, Plant & Equipment
-0---
Upgrade
Investment in Securities
---0.460.02
Upgrade
Investing Cash Flow
-0-00.450.02
Upgrade
Long-Term Debt Issued
----0.24
Upgrade
Total Debt Issued
----0.24
Upgrade
Short-Term Debt Repaid
-0.5-0.62---
Upgrade
Total Debt Repaid
-0.5-0.62---
Upgrade
Net Debt Issued (Repaid)
-0.5-0.62--0.24
Upgrade
Issuance of Common Stock
0.07000.5410.35
Upgrade
Other Financing Activities
100.314.197.939.19-
Upgrade
Financing Cash Flow
99.8713.577.939.7410.6
Upgrade
Net Cash Flow
85.067.67-3.46-0.671.34
Upgrade
Free Cash Flow
-14.81-5.9-11.39-10.86-9.28
Upgrade
Free Cash Flow Per Share
-0.42-23.76-619.37-844.53-
Upgrade
Levered Free Cash Flow
-9.41-3.79-7.77-19.33-5.49
Upgrade
Unlevered Free Cash Flow
-9.39-3.77-7.76-19.33-5.49
Upgrade
Change in Net Working Capital
-1.66-1.171.330.5-0.22
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q